Dr. Rariy is a Chief Health Officer and Senior Vice President of Digital Health at Oncology Care Partners, a first-of-its kind platform, purpose-built, patient-focused oncology value-based care network. She oversees oncology innovation delivery systems and leads digital transformation, artificial intelligence and machine learning, and emerging technologies strategy. In addition to being a healthcare executive, she is a practicing Endocrinologist with a focus on endocrine oncology, investor, keynote speaker, peer reviewed author, and serves on several non-profit and private boards that support the advancement of digital health, technology and equity. Dr. Rariy has more than 15 years’ experience within the digital health and medical technology industry. Most recently she served as venture partner at Takeda Digital Ventures, Takeda Pharmaceuticals and prior to that held senior executive roles in various markets including pharmaceuticals, government, academic, private, Fortune 5 “Big Tech” (Amazon Care at Amazon, Inc.), to start-up. With such a unique combination of expertise and perspective, she has been recognized by ASCO/AVBCC as “40 under 40” in Cancer Innovation. She is the co-founder of Equity in STEMM, Innovation, & AI, which collaborates with academia, industry, and policymakers to overcome barriers in healthcare and amplify the STEMM (Science, Technology, Engineering, Mathematics, and Medicine) potential of underrepresented communities. Dr. Rariy is board certified in Internal Medicine and Endocrinology, fellowship trained in clinical and research at Harvard Medical School’s Brigham & Women’s Hospital and University of Pittsburgh Medical Center (UPMC), with a medical degree from Harvard Medical School.